GLP1R and congestive heart failure: Chronic treatment with either GLP-1 or AC3174, a peptide analogue with pharmacologic properties similar to the GLP-1R agonist exenatide, showed cardioprotective effects and improved cardiac function, cardiac remodeling, insulin sensitivity, and exercise capacity in myocardial infarction rats with chronic heart failure[45].